| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.27929 |
| P698 | PubMed publication ID | 26054020 |
| P50 | author | Xianghuo He | Q39051788 |
| P2093 | author name string | Jinjun Li | |
| Jianren Gu | |||
| Ming Yao | |||
| Yingjun Zhao | |||
| Zhaoping Qiu | |||
| Qifeng Wang | |||
| Ning Tan | |||
| Zhichao Wang | |||
| Shenglin Huang | |||
| Weijie Guo | |||
| Taoyang Chen | |||
| Zhiao Chen | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy | Q24646296 | ||
| MiR-15a and miR-16-1 cluster functions in human leukemia | Q24647555 | ||
| MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2 | Q24655427 | ||
| Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha | Q24814445 | ||
| On the Origin of Cancer Cells | Q27861025 | ||
| Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α | Q28259513 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation | Q28294729 | ||
| Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival | Q28383106 | ||
| MicroRNAs in Cancer | Q29615539 | ||
| MicroRNAs in metabolism and metabolic disorders | Q33612997 | ||
| Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis | Q33623036 | ||
| MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells | Q34301072 | ||
| Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival | Q34447257 | ||
| Functional screening identifies miRNAs inducing cardiac regeneration. | Q34504097 | ||
| Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. | Q34742406 | ||
| Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs | Q34803043 | ||
| A novel miR-155/miR-143 cascade controls glycolysis by regulatinghexokinase 2in breast cancer cells | Q35931759 | ||
| MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene | Q36080463 | ||
| Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer | Q37120167 | ||
| Rethinking the Warburg effect with Myc micromanaging glutamine metabolism | Q37677940 | ||
| Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis | Q37701960 | ||
| Long-term experience with liver transplantation for hepatocellular carcinoma | Q37780114 | ||
| Lactate: a metabolic key player in cancer | Q37956296 | ||
| MicroRNAs and the Warburg Effect: new players in an old arena. | Q38031581 | ||
| Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p | Q38346113 | ||
| Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion | Q39029459 | ||
| Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme | Q39606772 | ||
| miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines. | Q39635207 | ||
| Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma | Q39958103 | ||
| Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase | Q41654938 | ||
| MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes | Q43066883 | ||
| Hypoxia, HIF1 and glucose metabolism in the solid tumour | Q44633634 | ||
| HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak | Q46726814 | ||
| Identification of metastasis-related microRNAs in hepatocellular carcinoma | Q51897320 | ||
| Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues | Q51958786 | ||
| Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. | Q54737658 | ||
| MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. | Q55444653 | ||
| Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma | Q61645725 | ||
| Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect | Q86909419 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1132-1144 | |
| P577 | publication date | 2015-07-04 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. | |
| P478 | volume | 62 |
| Q91198333 | 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects |
| Q55516475 | A novel RNA sequencing-based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma. |
| Q64070924 | B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2 |
| Q37472263 | Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison |
| Q88097347 | Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression |
| Q90169691 | Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation |
| Q58746444 | Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression |
| Q83600815 | Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway |
| Q40786667 | Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma |
| Q37580255 | Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma |
| Q59126036 | Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer |
| Q44845721 | Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer |
| Q60952463 | EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma |
| Q97419057 | Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma |
| Q64240700 | Epigenetics of hepatocellular carcinoma |
| Q64266344 | Ferroptosis is governed by differential regulation of transcription in liver cancer |
| Q64125674 | HIF-2α, acting miR-191, is involved in angiogenesis and metastasis of arsenite-transformed HBE cells |
| Q99565364 | HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway |
| Q89582312 | Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease |
| Q52631133 | In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases. |
| Q26739857 | Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism |
| Q33648885 | Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells |
| Q64072315 | Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer |
| Q55073980 | Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma. |
| Q55869540 | Metabolic recoding of epigenetics in cancer |
| Q38823802 | MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development |
| Q38713585 | MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma |
| Q92983364 | MiR-638 Repressed Vascular Smooth Muscle Cell Glycolysis by Targeting LDHA |
| Q39189133 | MicroRNA regulation and analytical methods in cancer cell metabolism |
| Q55258939 | MicroRNA-129-5p Regulates Glycolysis and Cell Proliferation by Targeting the Glucose Transporter SLC2A3 in Gastric Cancer Cells. |
| Q38733816 | MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells |
| Q38763929 | MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene |
| Q52935983 | MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells |
| Q92541923 | MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities |
| Q50067689 | MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism |
| Q64234430 | Micromanaging aerobic respiration and glycolysis in cancer cells |
| Q47143083 | Mitochondrial calcium uniporter as a target of microRNA-340 and promoter of metastasis via enhancing the Warburg effect. |
| Q47109133 | Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma |
| Q33702300 | Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. |
| Q47215507 | Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications |
| Q96609205 | Noncoding RNAs: the shot callers in tumor immune escape |
| Q49959240 | Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway |
| Q92068838 | Overview of microRNA-199a Regulation in Cancer |
| Q30234765 | Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis |
| Q36185753 | Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis |
| Q42516352 | Regulation of Glycolytic Metabolism by Autophagy in Liver Cancer Involves Selective Autophagic Degradation of HK2 (hexokinase 2). |
| Q37520359 | Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma |
| Q90483938 | Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis |
| Q61807597 | Regulatory effect of miR-421 on humeral fracture and heterotopic ossification in elderly patients |
| Q33586833 | Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death |
| Q47155641 | Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones |
| Q41377011 | Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization |
| Q41700266 | Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer. |
| Q36270963 | Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma |
| Q38627909 | Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma |
| Q45419184 | The Glycolytic Switch in Tumors: How Many Players Are Involved? |
| Q87418776 | The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer |
| Q98946913 | The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer |
| Q33779972 | The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma |
| Q46488114 | The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis |
| Q39072215 | The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication |
| Q26766079 | The sweet trap in tumors: aerobic glycolysis and potential targets for therapy |
| Q89285822 | Upregulation of miR-199a-5p Protects Spinal Cord Against Ischemia/Reperfusion-Induced Injury via Downregulation of ECE1 in Rat |
| Q42371270 | miR-125a suppresses viability and glycolysis and induces apoptosis by targeting Hexokinase 2 in laryngeal squamous cell carcinoma |
| Q50042578 | miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. |
| Q36191985 | miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. |
| Q89712521 | miR-199a-5p inhibits proliferation and induces apoptosis in hemangioma cells through targeting HIF1A |
| Q59809168 | miR-517a promotes Warburg effect in HCC by directly targeting FBP1 |
| Q90719437 | miR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer |
| Q51763083 | miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy |
| Q90119648 | miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2 |
| Q53181847 | microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect |
Search more.